231 related articles for article (PubMed ID: 19830784)
1. Association of CD14 variant with prostate cancer in African American men.
Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
[TBL] [Abstract][Full Text] [Related]
2. The CD14 rs2569190 TT Genotype is Associated with Chronic Periodontitis.
Ishaan D; Parthasarathy H; Ponnaiyan D; Tadepalli A
Genet Test Mol Biomarkers; 2017 Sep; 21(9):560-564. PubMed ID: 28829191
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity of CD14, CD28, CTLA-4 and ICOS gene promoter polymorphism in African and American sickle cell disease.
Seamans BN; Pellechio SL; Capria AL; Agyingi SE; Morenikeji OB; Ojurongbe O; Thomas BN
Hum Immunol; 2019 Nov; 80(11):930-936. PubMed ID: 31474499
[TBL] [Abstract][Full Text] [Related]
4. [Effect of CD14 promoter variants on the susceptibility to laryngeal cancer].
Yang L; Wen S; Lin J; Zhang X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 51(3):197-202. PubMed ID: 27033574
[TBL] [Abstract][Full Text] [Related]
5. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans.
Hooker S; Bonilla C; Akereyeni F; Ahaghotu C; Kittles RA
Prostate Cancer Prostatic Dis; 2008; 11(4):349-56. PubMed ID: 18026184
[TBL] [Abstract][Full Text] [Related]
6. Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.
Lachance J; Berens AJ; Hansen MEB; Teng AK; Tishkoff SA; Rebbeck TR
Cancer Res; 2018 May; 78(9):2432-2443. PubMed ID: 29438991
[TBL] [Abstract][Full Text] [Related]
7. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
[TBL] [Abstract][Full Text] [Related]
8. Replication of prostate cancer risk loci in a Japanese case-control association study.
Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
[TBL] [Abstract][Full Text] [Related]
9. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
10. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
[TBL] [Abstract][Full Text] [Related]
11. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.
Zheng SL; Augustsson-Bälter K; Chang B; Hedelin M; Li L; Adami HO; Bensen J; Li G; Johnasson JE; Turner AR; Adams TS; Meyers DA; Isaacs WB; Xu J; Grönberg H
Cancer Res; 2004 Apr; 64(8):2918-22. PubMed ID: 15087412
[TBL] [Abstract][Full Text] [Related]
12. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
13. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
Fernandez P; de Beer PM; van der Merwe L; Heyns CF
Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.
Wang Y; Ray AM; Johnson EK; Zuhlke KA; Cooney KA; Lange EM
Prostate; 2011 Feb; 71(3):225-31. PubMed ID: 20717903
[TBL] [Abstract][Full Text] [Related]
15. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
[TBL] [Abstract][Full Text] [Related]
16. EphB2 SNPs and sporadic prostate cancer risk in African American men.
Robbins CM; Hooker S; Kittles RA; Carpten JD
PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
[TBL] [Abstract][Full Text] [Related]
17. Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis.
Wu Q; Xu X; Ren J; Liu S; Liao X; Wu X; Hu D; Wang G; Gu G; Kang Y; Li J
BMC Anesthesiol; 2017 Jan; 17(1):11. PubMed ID: 28122493
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men.
Hughes L; Ruth K; Rebbeck TR; Giri VN
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):308-14. PubMed ID: 24061634
[TBL] [Abstract][Full Text] [Related]
19. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
Paris PL; Kupelian PA; Hall JM; Williams TL; Levin H; Klein EA; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):901-5. PubMed ID: 10548319
[TBL] [Abstract][Full Text] [Related]
20. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
